USP, government labs to launch drug quality network; GSK adds solar panels in RTP;

> The United States Pharmacopeial Convention and six government drug control labs in the Middle East and Northern Africa have joined to launch a drug quality improvement network. Article

> GlaxoSmithKline is preparing to install more solar panels at its Research Triangle Park campus. Item

> One-third of those polled say they are not sure if their company's CAPA system is robust enough to withstand a regulatory inspection. Release

> Officials in China believe they may have found the facility used to make counterfeits of Roche's Avastin. Article

> Cangene answers questions about its conversion to an electronic system for managing the training of plant workers. Interview

> Capillary electrophoresis machines are ready for installation in Cambodia and Congo, part of a European initiative to use the low-cost, easy to operate gear to analyze commonly counterfeited medicines. Article

> Material costs for plastic bottles and blister packs have risen by double-digit percentages over the past two years. Release

> Officials have approved a plan for connecting a Merck facility with the local water treatment plant to accommodate 300,000 gallons per day, about one-third of the West Point, PA, plant's wastewater. News

> Canada's Paralympic gold medal-winning curling team captain has pleaded guilty in the U.S. to selling counterfeit erectile-dysfunction drugs. Article

> Albania is setting up a pharmacovigilance center to monitor undesirable drug effects and develop measures for their prevention. Story

> Microscan has unveiled VS-1 Track and Trace, a solution for inspecting and verifying package label content. Microscan release

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

Roche will spend $500 million for a new global manufacturing logistics hub in Canada that will eventually employ 500 workers in Ontario.

Fledgling Indiana CDMO Incog BioPharma Services is shelling out $60 million to get its first manufacturing facility off the ground.